Navigation Links
Cepheid Announces European Release of Xpert Flu, Delivering Simultaneous Detection and Differentiation of Flu A, Flu B, and 2009 H1N1 Strain
Date:12/27/2010

lable in the United States in early 2011.

About CepheidBased in Sunnyvale, Calif., Cepheid (Nasdaq: CPHD) is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the company's solutions deliver a better way for institutions of any size to perform sophisticated genetic testing for organisms and genetic-based diseases. Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer. For more information, visit http://www.cepheid.com.

This press release contains forward-looking statements that are not purely historical regarding Cepheid's or its management's intentions, beliefs, expectations and strategies for the future, including those relating to the timing of new product releases, regulatory developments and approvals, product availability in specified markets, and product performance. Because such statements deal with future events, they are subject to various risks and uncertainties, and actual results could differ materially from the company's current expectations. Factors that could cause actual results to differ materially include risks and uncertainties such as those relating to: product development and manufacturing problems; uncertainties in the regulatory review process for new products; regulatory developments and practices regarding testing; customer and market acceptance of the product; the failure of the product to perform as expected, whether due to manufacturing errors, design defects or otherwise; the impact of competitive products and pricing; potentially lengthy sales cycles i
'/>"/>

SOURCE Cepheid
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cepheid Announces Termination of Contract With the Centers for Disease Control and Prevention to Develop Rapid Point of Care Test for Avian Influenza
2. Cepheid Launches New GeneXpert(R) Tests in Europe for Simultaneous, Rapid Detection of Staphylococcus Aureus and Methicillin Resistant Staphylococcus Aureus
3. Cepheid GeneXpert(R) System and Xpert(TM) MRSA Selected for up to 11 Victoria, Australia Hospitals in Rollout of Start Clean Strategy
4. Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection
5. Cepheid Molecular Diagnostic Test for Positive Blood Culture Bottles Categorized Moderate Complexity by FDA
6. Cepheid Announces European Release of First On-Demand Molecular Test for Simultaneous Detection of Mycobacterium tuberculosis (TB) and Resistance to Rifampicin
7. Cepheid Receives Grant to Develop Ten-Color Real-Time PCR Detection Technology for Use in the GeneXpert(R) System
8. Cepheid Reports 2009 Third Quarter Results
9. Cepheid to Webcast Upcoming Financial Presentations
10. Cepheid Collaborates With Pharmaceutical Leader on Chronic Myelogenous Leukemia
11. Cepheid to Webcast Upcoming Financial Presentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)...  Bayer HealthCare and Orion Corporation, a pharmaceutical ... , have begun to enroll patients in a ... androgen receptor inhibitor in clinical development. The study, ... prostate cancer who have rising Prostate Specific Antigen ... is designed to determine the effects of the ...
(Date:9/15/2014)...  Patients in today,s changing health care landscape are ... outpatient setting versus a hospital. In an effort to ... patients continue to receive high quality medical care; Kaiser ... internal medicine residency program. The program,s progressive curriculum will ... and even virtual settings. "We are ...
(Date:9/15/2014)... and BRUSSELS , Sept. 15, 2014 ... UCB (Euronext Brussels:UCB) today announced results from several exploratory ... postmenopausal women with low bone mineral density (BMD). Romosozumab ... work by inhibiting the protein sclerostin, thereby increasing bone ... at the American Society for Bone and Mineral Research ...
Breaking Medicine Technology:Bayer and Orion Initiate Phase III Trial of ODM-201 in Men with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer 2Bayer and Orion Initiate Phase III Trial of ODM-201 in Men with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer 3Kaiser Permanente Hawaii Launches New Internal Medicine Residency Program 2Kaiser Permanente Hawaii Launches New Internal Medicine Residency Program 3New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 2New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 3New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 4New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 5New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 6New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 7New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 8New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 9New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 10New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 11New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 12New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 13New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 14New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 15
... Publicis Groupe announced today that ... Healthcare Communications Group (PHCG), powerfully redefining Publicis Groupe,s ... healthcare sector. PHCG is the world,s ... Digitas Health and Razorfish Health -- Publicis Groupe,s ...
... 27, 2011 Halozyme Therapeutics, Inc. (NASDAQ: ... targeting the extracellular matrix for the diabetes, ... results from a study in patients with type 1 ... Phase 1b study was conducted as a randomized, double-blind, ...
Cached Medicine Technology:Publicis Healthcare Communications Group Redefines Publicis Groupe's Healthcare Client Offering by Joining Forces with Digitas Health and Razorfish Health 2Publicis Healthcare Communications Group Redefines Publicis Groupe's Healthcare Client Offering by Joining Forces with Digitas Health and Razorfish Health 3Publicis Healthcare Communications Group Redefines Publicis Groupe's Healthcare Client Offering by Joining Forces with Digitas Health and Razorfish Health 4Publicis Healthcare Communications Group Redefines Publicis Groupe's Healthcare Client Offering by Joining Forces with Digitas Health and Razorfish Health 5Halozyme Therapeutics Announces Positive Results From Enzyme-Augmented Insulin Pump Trial 2Halozyme Therapeutics Announces Positive Results From Enzyme-Augmented Insulin Pump Trial 3Halozyme Therapeutics Announces Positive Results From Enzyme-Augmented Insulin Pump Trial 4
(Date:9/16/2014)... 16, 2014 Non-small cell lung cancer (NSCLC) survivors ... at the time of diagnosis have a lower ... compared to those who are current smokers, suggesting ... higher risk of SPLC, according to research presented ... (ASTRO,s) 56th Annual Meeting. , The analysis studied ...
(Date:9/16/2014)... 16, 2014 An experimental positron emission ... disease while a person is still alive, according to ... Medicine at Mount Sinai, and at Molecular Neuroimaging (MNI) ... the journal Translational Psychiatry. , Specifically, the study results ... which is designed to latch onto a protein called ...
(Date:9/16/2014)... VA (PRWEB) September 16, 2014 Gary ... Republic of China, has selected Worldwide Speakers Group for ... former U.S. Secretary of Commerce and Governor of Washington, ... foremost authorities on U.S.-China relations, global expansion, and business ... on global competitiveness and how to grow an organization’s ...
(Date:9/16/2014)... September 16, 2014 The Muscular ... of flu vaccines for individuals affected by muscle ... and other neuromuscular diseases. , MDA offers this ... muscle disease who, because of compromised respiratory function ... the lungs — are at increased risk of ...
(Date:9/16/2014)... Insuranceservicecompany.com has released a new blog post explaining ... , Whole life insurance can provide financial security for ... an investment tool. Clients can save money for retirement using ... A whole life insurance plan features a savings account which ... this policy to be profitable, clients should purchase it as ...
Breaking Medicine News(10 mins):Health News:NSCLC patients who never smoked or who quit smoking have lower risk of developing secondary cancers 2Health News:NSCLC patients who never smoked or who quit smoking have lower risk of developing secondary cancers 3Health News:Neuroimaging Technique Identifies Concussion-Related Brain Disease in Living Brain 2Health News:Neuroimaging Technique Identifies Concussion-Related Brain Disease in Living Brain 3Health News:Neuroimaging Technique Identifies Concussion-Related Brain Disease in Living Brain 4Health News:Gary Locke, Former Ambassador to China, Selects Worldwide Speakers Group for Exclusive Lecture Representation 2Health News:MDA Offers Flu Shots to Those Affected by Muscle Disease 2Health News:Whole Life Insurance Can Be A Good Investment Tool for Retirement! 2
... The Midwest Center for Stress and Anxiety announced ... the premier online destination for news, information and solutions ... new site features an enhanced user interface with access ... most pressing and relevant stress-related issues, and the newest ...
... Arizona Technology Enterprises (AzTE), the technology venturing arm ... technology forum for investors on Feb. 12 and 13, ... in Scottsdale, AzTE collaborated with its tech transfer partner, ... The forum was sponsored and supported by Silicon ...
... FRANCISCO, Feb. 18 DIAKADI Body, Personal ... its outdoor boot camps, the hottest and most economical workout ... a.m., individuals of all fitness levels will gather in Mission ... Stairs) to take their workout to the next level. ...
... Verathon(R) is pleased to announce,the GlideScope(R) Ranger Video ... States Army.(1) This certificate allows the,device to be ... of the most,demanding military settings. , ... The U.S. Army Airworthiness ...
... Achieves 20% Sales Growth over Q3 FY 08 and Record Quarterly ... ) today announced results for the quarter ended January 23, 2009. ... of fiscal 2009 compared to the third quarter of fiscal 2008 ... Net sales of $35.3 million, a 20% increase ...
... proves faster, more accurate in early tests , , WEDNESDAY, ... make prescribing the widely used anticoagulant warfarin safer by ... , The U.S. Food and Drug Administration estimates that ... blood clots that can cause strokes. Reasons range from ...
Cached Medicine News:Health News:The Midwest Center for Stress and Anxiety Re-launches Website for Stress, Anxiety, and Depression 2Health News:Arizona Technology Enterprises (AzTE) Hosts the ASU Tech Forum for the Investment Community 2Health News:Arizona Technology Enterprises (AzTE) Hosts the ASU Tech Forum for the Investment Community 3Health News:Arizona Technology Enterprises (AzTE) Hosts the ASU Tech Forum for the Investment Community 4Health News:Back by Popular Demand! DIAKADI Body Announces Its Spring Edition of Outdoor Boot Camps 2Health News:Back by Popular Demand! DIAKADI Body Announces Its Spring Edition of Outdoor Boot Camps 3Health News:GlideScope(R) Ranger Video Laryngoscope by Verathon(R) Awarded Airworthiness Certification by U.S. Army 2Health News:GlideScope(R) Ranger Video Laryngoscope by Verathon(R) Awarded Airworthiness Certification by U.S. Army 3Health News:Cyberonics Continues Strong Sales Growth and Profitability in Fiscal 2009 Third Quarter 2Health News:Cyberonics Continues Strong Sales Growth and Profitability in Fiscal 2009 Third Quarter 3Health News:Cyberonics Continues Strong Sales Growth and Profitability in Fiscal 2009 Third Quarter 4Health News:Cyberonics Continues Strong Sales Growth and Profitability in Fiscal 2009 Third Quarter 5Health News:Cyberonics Continues Strong Sales Growth and Profitability in Fiscal 2009 Third Quarter 6Health News:Cyberonics Continues Strong Sales Growth and Profitability in Fiscal 2009 Third Quarter 7Health News:Cyberonics Continues Strong Sales Growth and Profitability in Fiscal 2009 Third Quarter 8Health News:Cyberonics Continues Strong Sales Growth and Profitability in Fiscal 2009 Third Quarter 9Health News:Cyberonics Continues Strong Sales Growth and Profitability in Fiscal 2009 Third Quarter 10Health News:Cyberonics Continues Strong Sales Growth and Profitability in Fiscal 2009 Third Quarter 11Health News:Genetics May Help Fine-Tune Warfarin Dosage 2Health News:Genetics May Help Fine-Tune Warfarin Dosage 3Health News:Genetics May Help Fine-Tune Warfarin Dosage 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: